skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Regioselective alkane hydroxylation with a mutant CYP153A6 enzyme

Abstract

Cytochrome P450 CYP153A6 from Myobacterium sp. strain HXN1500 was engineered using in-vivo directed evolution to hydroxylate small-chain alkanes regioselectively. Mutant CYP153A6-BMO1 selectively hydroxylates butane and pentane at the terminal carbon to form 1-butanol and 1-pentanol, respectively, at rates greater than wild-type CYP153A6 enzymes. This biocatalyst is highly active for small-chain alkane substrates and the regioselectivity is retained in whole-cell biotransformations.

Inventors:
;
Issue Date:
Research Org.:
California Institute of Technology (CalTech), Pasadena, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1082682
Patent Number(s):
8,361,769
Application Number:
12/619,033
Assignee:
U.S. Department of Energy (Washington, DC)
DOE Contract Number:  
FG02-06ER15762
Resource Type:
Patent
Resource Relation:
Patent File Date: 2009 Nov 16
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Koch, Daniel J., and Arnold, Frances H. Regioselective alkane hydroxylation with a mutant CYP153A6 enzyme. United States: N. p., 2013. Web.
Koch, Daniel J., & Arnold, Frances H. Regioselective alkane hydroxylation with a mutant CYP153A6 enzyme. United States.
Koch, Daniel J., and Arnold, Frances H. Tue . "Regioselective alkane hydroxylation with a mutant CYP153A6 enzyme". United States. https://www.osti.gov/servlets/purl/1082682.
@article{osti_1082682,
title = {Regioselective alkane hydroxylation with a mutant CYP153A6 enzyme},
author = {Koch, Daniel J. and Arnold, Frances H.},
abstractNote = {Cytochrome P450 CYP153A6 from Myobacterium sp. strain HXN1500 was engineered using in-vivo directed evolution to hydroxylate small-chain alkanes regioselectively. Mutant CYP153A6-BMO1 selectively hydroxylates butane and pentane at the terminal carbon to form 1-butanol and 1-pentanol, respectively, at rates greater than wild-type CYP153A6 enzymes. This biocatalyst is highly active for small-chain alkane substrates and the regioselectivity is retained in whole-cell biotransformations.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2013},
month = {1}
}

Patent:

Save / Share:

Works referenced in this record:

In Vivo Evolution of Butane Oxidation by Terminal Alkane Hydroxylases AlkB and CYP153A6
journal, November 2008

  • Koch, D. J.; Chen, M. M.; van Beilen, J. B.
  • Applied and Environmental Microbiology, Vol. 75, Issue 2
  • DOI: 10.1128/AEM.01758-08

Alkane hydroxylases involved in microbial alkane degradation
journal, January 2007

  • van Beilen, Jan B.; Funhoff, Enrico G.
  • Applied Microbiology and Biotechnology, Vol. 74, Issue 1
  • DOI: 10.1007/s00253-006-0748-0

Regio- and Enantioselective Alkane Hydroxylation with Engineered Cytochromes P450 BM-3
journal, November 2003

  • Peters, Matthew W.; Meinhold, Peter; Glieder, Anton
  • Journal of the American Chemical Society, Vol. 125, Issue 44, p. 13442-13450
  • DOI: 10.1021/ja0303790

Engineered Alkane-Hydroxylating Cytochrome P450BM3 Exhibiting Nativelike Catalytic Properties
journal, November 2007

  • Fasan, Rudi; Chen, Mike M.; Crook, Nathan C.
  • Angewandte Chemie International Edition, Vol. 46, Issue 44, p. 8414-8418
  • DOI: 10.1002/anie.200702616

Engineering cytochrome P450cam into an alkane hydroxylase
journal, January 2003

  • Bell, Stephen G.; Orton, Erica; Boyd, Helen
  • Dalton Transactions, Issue 11
  • DOI: 10.1039/b300869j